{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:31:38Z","timestamp":1787927498390,"version":"build-2784847793"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["D-0005"],"award-info":[{"award-number":["D-0005"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001027","name":"CH Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01GM130091- 06"],"award-info":[{"award-number":["1R01GM130091- 06"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01GM112490- 10"],"award-info":[{"award-number":["1R01GM112490- 10"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytica Chimica Acta"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.aca.2026.345882","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T23:45:48Z","timestamp":1782431148000},"page":"345882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Advanced glycomics approach for characterization of IgG glycan alterations and immune modulation in traumatic brain injury"],"prefix":"10.1016","volume":"1420","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6791-7989","authenticated-orcid":false,"given":"Sherifdeen","family":"Onigbinde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Sandilya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0394-3683","authenticated-orcid":false,"given":"Oluwatosin","family":"Daramola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9168-5396","authenticated-orcid":false,"given":"Mojibola","family":"Fowowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5088-4277","authenticated-orcid":false,"given":"Moyinoluwa","family":"Adeniyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5008-6944","authenticated-orcid":false,"given":"Firas H.","family":"Kobeissy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8587-3614","authenticated-orcid":false,"given":"Stefania","family":"Mondello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2569-9607","authenticated-orcid":false,"given":"Ava M.","family":"Puccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6661-6073","authenticated-orcid":false,"given":"Yehia","family":"Mechref","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aca.2026.345882_bib1","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3171\/2017.10.JNS17352","article-title":"Estimating the global incidence of traumatic brain injury","volume":"130","author":"Dewan","year":"2018","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.aca.2026.345882_bib2","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S1474-4422(22)00309-X","article-title":"Traumatic brain injury: progress and challenges in prevention, clinical care, and research","volume":"21","author":"Maas","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.aca.2026.345882_bib3","series-title":"Traumatic Brain Injury, Braddom\u2019s Physical Medicine and Rehabilitation","first-page":"916","author":"Wagner","year":"2021"},{"key":"10.1016\/j.aca.2026.345882_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105210","article-title":"Mechanosensation in traumatic brain injury","volume":"148","author":"Keating","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.aca.2026.345882_bib5","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1089\/neu.2021.0062","article-title":"Epidemiology of chronic effects of traumatic brain injury","volume":"38","author":"Haarbauer-Krupa","year":"2021","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.aca.2026.345882_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.biopsych.2021.09.024","article-title":"Mental health consequences of traumatic brain injury","volume":"91","author":"Howlett","year":"2022","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.aca.2026.345882_bib7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13049-022-01050-0","article-title":"Moderate and severe traumatic brain injury in general hospitals: a ten-year population-based retrospective cohort study in central Norway","volume":"30","author":"Rahim","year":"2022","journal-title":"Scand. J. Trauma Resuscitation Emerg. Med."},{"key":"10.1016\/j.aca.2026.345882_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40478-020-00924-7","article-title":"Biological links between traumatic brain injury and Parkinson\u2019s disease","volume":"8","author":"Delic","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.aca.2026.345882_bib9","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jamaneurol.2016.1948","article-title":"Association of traumatic brain injury with late-life neurodegenerative conditions and neuropathologic findings","volume":"73","author":"Crane","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.aca.2026.345882_bib10","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1089\/neu.2013.3303","article-title":"Linking traumatic brain injury to chronic traumatic encephalopathy: identification of potential mechanisms leading to neurofibrillary tangle development","volume":"31","author":"Lucke-Wold","year":"2014","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.aca.2026.345882_bib11","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s12031-021-01841-7","article-title":"Traumatic brain injury: mechanistic insight on pathophysiology and potential therapeutic targets","volume":"71","author":"Thapa","year":"2021","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.aca.2026.345882_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.740939","article-title":"Traumatic brain injury: mechanisms of glial response","volume":"12","author":"Mira","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.aca.2026.345882_bib13","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3390\/cells10051009","article-title":"Traumatic brain injury: ultrastructural features in neuronal ferroptosis, glial cell activation and polarization, and blood\u2013brain barrier breakdown","volume":"10","author":"Qin","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.aca.2026.345882_bib14","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/fcp.12767","article-title":"Oxidative stress and mitochondrial dysfunction following traumatic brain injury: from mechanistic view to targeted therapeutic opportunities","volume":"36","author":"Hakiminia","year":"2022","journal-title":"Fund. Clin. Pharmacol."},{"key":"10.1016\/j.aca.2026.345882_bib15","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S1474-4422(14)70120-6","article-title":"The Glasgow Coma Scale at 40 years: standing the test of time","volume":"13","author":"Teasdale","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.aca.2026.345882_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/14737159.2024.2306876","article-title":"The game changer: UCH-L1 and GFAP-based blood test as the first marketed in vitro diagnostic test for mild traumatic brain injury","volume":"24","author":"Kobeissy","year":"2024","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.aca.2026.345882_bib17","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1089\/neu.2023.0186","article-title":"Diagnostic utility of glial fibrillary acidic protein beyond 12 hours after traumatic brain injury: a TRACK-TBI study","volume":"41","author":"Puccio","year":"2024","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.aca.2026.345882_bib18","first-page":"1","article-title":"Immune response in traumatic brain injury","author":"C\u00e1ceres","year":"2024","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.aca.2026.345882_bib19","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3389\/fimmu.2016.00556","article-title":"Emerging roles for the immune system in traumatic brain injury","volume":"7","author":"McKee","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.aca.2026.345882_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.995044","article-title":"Immune modulation after traumatic brain injury","volume":"9","author":"Bouras","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.aca.2026.345882_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuron.2015.05.019","article-title":"Dealing with danger in the CNS: the response of the immune system to injury","volume":"87","author":"Gadani","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.aca.2026.345882_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/251204","article-title":"Neurotrauma and inflammation: CNS and PNS responses","volume":"2015","author":"Mietto","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.aca.2026.345882_bib23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11064-024-04316-4","article-title":"Neuroinflammatory response in the traumatic brain injury: an update","volume":"50","author":"Kursancew","year":"2024","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.aca.2026.345882_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1088827","article-title":"Neuroinflammation of traumatic brain injury: roles of extracellular vesicles","volume":"13","author":"Liu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.aca.2026.345882_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2024.111066","article-title":"Neuroimmune and neuroinflammation response for traumatic brain injury","volume":"217","author":"Wu","year":"2024","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.aca.2026.345882_bib26","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.7150\/ijms.46834","article-title":"The peripheral immune system and traumatic brain injury: insight into the role of T-helper cells","volume":"18","author":"Bao","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.aca.2026.345882_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.825086","article-title":"Microglia and neuroinflammation: crucial pathological mechanisms in traumatic brain injury-induced neurodegeneration","volume":"14","author":"Shao","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.aca.2026.345882_bib28","article-title":"Neuroinflammation following traumatic brain injury: take it seriously or not","volume":"13","author":"Zheng","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.aca.2026.345882_bib29","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41577-020-00410-0","article-title":"The role of IgG Fc receptors in antibody-dependent enhancement","volume":"20","author":"Bournazos","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.aca.2026.345882_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-015-0450-1","article-title":"Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid","volume":"12","author":"Wuhrer","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.aca.2026.345882_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1006939","article-title":"IgG subclass and Fc glycosylation shifts are linked to the transition from pre-to inflammatory autoimmune conditions","volume":"13","author":"Buhre","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.aca.2026.345882_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.929895","article-title":"Role of Fc core fucosylation in the effector function of IgG1 antibodies","volume":"13","author":"Golay","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.aca.2026.345882_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.818736","article-title":"Sialylation as an important regulator of antibody function","volume":"13","author":"Vattepu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.aca.2026.345882_bib34","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00018-016-2366-z","article-title":"Regulation of antibody effector functions through IgG Fc N-glycosylation","volume":"74","author":"Quast","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.aca.2026.345882_bib35","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11481-021-09996-1","article-title":"Aberrant immunoglobulin G glycosylation in multiple sclerosis","volume":"17","author":"Kennedy","year":"2022","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.aca.2026.345882_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1257906","article-title":"Association between immunoglobulin G N-glycosylation and lupus nephritis in female patients with systemic lupus erythematosus: a case-control study","volume":"14","author":"Lu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.aca.2026.345882_bib37","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.immuni.2022.11.014","article-title":"Immune checkpoint therapy-elicited sialylation of IgG antibodies impairs antitumorigenic type I interferon responses in hepatocellular carcinoma","volume":"56","author":"Wu","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.aca.2026.345882_bib38","article-title":"Revealing the changes of IgG subclass\u2010specific N\u2010glycosylation in colorectal cancer progression by high\u2010throughput assay","volume":"15","author":"Liu","year":"2021","journal-title":"Proteonomics Clin. Appl."},{"key":"10.1016\/j.aca.2026.345882_bib39","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.bbrc.2015.12.114","article-title":"Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption\/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls","volume":"469","author":"Kawaguchi-Sakita","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.aca.2026.345882_bib40","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3233\/JAD-131088","article-title":"Blood plasma IgG Fc glycans are significantly altered in Alzheimer\u2019s disease and progressive mild cognitive impairment","volume":"38","author":"Lundstr\u00f6m","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.aca.2026.345882_bib41","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1002\/alz.13124","article-title":"Fc n\u2010glycosylation of autoreactive A\u03b2 antibodies as a blood\u2010based biomarker for Alzheimer\u2019s disease","volume":"19","author":"Kronimus","year":"2023","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.aca.2026.345882_bib42","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/glycob\/cwx022","article-title":"The N-glycosylation of immunoglobulin G as a novel biomarker of Parkinson\u2019s disease","volume":"27","author":"Russell","year":"2017","journal-title":"Glycobiology"},{"key":"10.1016\/j.aca.2026.345882_bib43","first-page":"63","article-title":"IgG Fc glycosylation in human immunity","volume":"423","author":"Wang","year":"2019","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.aca.2026.345882_bib44","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1172\/JCI130029","article-title":"Functional diversification of IgGs through Fc glycosylation","volume":"129","author":"Wang","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.aca.2026.345882_bib45","unstructured":"R.J. Pleass, The Therapeutic Potential of Sialylated Fc Domains of Human Igg, Taylor & Francis, pp. 1953220."},{"key":"10.1016\/j.aca.2026.345882_bib46","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00216-016-9996-8","article-title":"LC-MS\/MS analysis of permethylated N-glycans facilitating isomeric characterization","volume":"409","author":"Zhou","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.aca.2026.345882_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/biom13091421","article-title":"N-Glycome profile of the spike protein S1: systemic and comparative analysis from eleven variants of SARS-CoV-2","volume":"13","author":"Reyes","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.aca.2026.345882_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1442772","article-title":"Neuroglycome alterations of hippocampus and prefrontal cortex of juvenile rats chronically exposed to glyphosate-based herbicide","volume":"18","author":"Solomon","year":"2024","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.aca.2026.345882_bib49","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1021\/acs.jproteome.5c00018","article-title":"Serum N-Glycan profiling identifies candidate glycan biomarkers for early detection and prediction of Alzheimer\u2019s Disease","volume":"24","author":"Onigbinde","year":"2025","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.aca.2026.345882_bib50","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1021\/acs.jproteome.3c00914","article-title":"O-Glycome profiling of breast cancer cell lines to understand breast cancer brain metastasis","volume":"23","author":"Onigbinde","year":"2024","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.aca.2026.345882_bib51","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1007\/s00216-010-3532-z","article-title":"Glycan labeling strategies and their use in identification and quantification","volume":"397","author":"Ruhaak","year":"2010","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.aca.2026.345882_bib52","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/rcm.3395","article-title":"High-throughput solid-phase permethylation of glycans prior to mass spectrometry","volume":"22","author":"Kang","year":"2008","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.aca.2026.345882_bib53","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1021\/acs.analchem.0c04395","article-title":"Mesoporous graphitized carbon column for efficient isomeric separation of permethylated glycans","volume":"93","author":"Gautam","year":"2021","journal-title":"Anal. Chem."},{"key":"10.1016\/j.aca.2026.345882_bib54","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jasms.2008.11.012","article-title":"The high mannose glycans from bovine ribonuclease B isomer characterization by ion trap MS","volume":"20","author":"Prien","year":"2009","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.aca.2026.345882_bib55","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1021\/acs.analchem.7b00747","article-title":"Isomeric separation of permethylated glycans by porous graphitic carbon (PGC)-LC-MS\/MS at high temperatures","volume":"89","author":"Zhou","year":"2017","journal-title":"Anal. Chem."},{"key":"10.1016\/j.aca.2026.345882_bib56","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1039\/D2AN00010E","article-title":"Isomeric separation of permethylated glycans by extra-long reversed-phase liquid chromatography (RPLC)-MS\/MS","volume":"147","author":"Wang","year":"2022","journal-title":"Analyst"},{"key":"10.1016\/j.aca.2026.345882_bib57","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12014-024-09516-2","article-title":"Identification of serum N-glycans signatures in three major gastrointestinal cancers by high-throughput N-glycome profiling","volume":"21","author":"Liu","year":"2024","journal-title":"Clin. Proteom."},{"key":"10.1016\/j.aca.2026.345882_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101494","article-title":"Exploring serum glycome patterns after moderate to severe traumatic brain injury: a prospective pilot study","volume":"50","author":"Mondello","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.aca.2026.345882_bib59","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/jssc.202000878","article-title":"Glycomics and glycoproteomics: approaches to address isomeric separation of glycans and glycopeptides","volume":"44","author":"Gutierrez Reyes","year":"2021","journal-title":"J. Separ. Sci."},{"key":"10.1016\/j.aca.2026.345882_bib60","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf6834","article-title":"Differential recognition of oligomannose isomers by glycan-binding proteins involved in innate and adaptive immunity","volume":"7","author":"Gao","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.aca.2026.345882_bib61","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3390\/biom12111657","article-title":"LC-MS\/MS isomeric profiling of N-Glycans derived from low-abundant serum glycoproteins in mild cognitive impairment patients","volume":"12","author":"Reyes","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.aca.2026.345882_bib62","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.1893427","article-title":"Fc galactosylation follows consecutive reaction kinetics and enhances immunoglobulin G hexamerization for complement activation","volume":"13","author":"Wei","year":"2021","journal-title":"mAbs"},{"key":"10.1016\/j.aca.2026.345882_bib63","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1021\/acs.jproteome.9b00429","article-title":"Revealing the biological attributes of N-Glycan isomers in breast cancer brain metastasis using Porous Graphitic Carbon (PGC) liquid chromatography-tandem mass spectrometry (LC-MS\/MS)","volume":"18","author":"Peng","year":"2019","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.aca.2026.345882_bib64","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1129594","article-title":"Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation","volume":"313","author":"Kaneko","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.aca.2026.345882_bib65","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/ni.2939","article-title":"Type I and type II Fc receptors regulate innate and adaptive immunity","volume":"15","author":"Pincetic","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.aca.2026.345882_bib66","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.7150\/thno.53961","article-title":"Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.aca.2026.345882_bib67","doi-asserted-by":"crossref","first-page":"8433","DOI":"10.1073\/pnas.0702936104","article-title":"Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity","volume":"104","author":"Nimmerjahn","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.aca.2026.345882_bib68","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3899\/jrheum.110584","article-title":"IgG glycosylation changes and MBL2 polymorphisms: associations with markers of systemic inflammation and joint destruction in rheumatoid arthritis","volume":"39","author":"Troelsen","year":"2012","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.aca.2026.345882_bib69","first-page":"16","volume":"vol. 5","author":"Xu","year":"2022"},{"key":"10.1016\/j.aca.2026.345882_bib70","article-title":"Reduced serum IgG galactosylation is associated with increased inflammation during relapses of neuromyelitis optica spectrum disorders","volume":"15","author":"Gao","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.aca.2026.345882_bib71","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12974-015-0450-1","article-title":"Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid","volume":"12","author":"Wuhrer","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.aca.2026.345882_bib72","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13075-018-1540-0","article-title":"Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity","volume":"20","author":"Schwedler","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.aca.2026.345882_bib73","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41420-024-02180-3","article-title":"Biological function of sialic acid and sialylation in human health and disease","volume":"10","author":"Zhu","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.aca.2026.345882_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.893365","article-title":"N-glycosylation and inflammation; the not-so-sweet relation","volume":"13","author":"Radovani","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.aca.2026.345882_bib75","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1093\/glycob\/cwu101","article-title":"Glycobiology of leukocyte trafficking in inflammation","volume":"24","author":"Wright","year":"2014","journal-title":"Glycobiology"},{"key":"10.1016\/j.aca.2026.345882_bib76","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1154315","article-title":"Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc","volume":"320","author":"Anthony","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.aca.2026.345882_bib77","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1080\/19420862.2019.1608143","article-title":"Effects of terminal galactose residues in mannose \u03b11-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies","volume":"11","author":"Aoyama","year":"2019","journal-title":"mAbs"},{"key":"10.1016\/j.aca.2026.345882_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.972168","article-title":"Specific location of galactosylation in an afucosylated antiviral monoclonal antibody affects its Fc\u03b3RIIIA binding affinity","volume":"13","author":"Hatfield","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.aca.2026.345882_bib79","article-title":"Human traumatic brain injury induces autoantibody response against glial fibrillary acidic protein and its breakdown products","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.aca.2026.345882_bib80","series-title":"Biomarkers for Traumatic Brain Injury","first-page":"431","article-title":"Chapter 29 - autoantibodies in central nervous system trauma: new frontiers for diagnosis and prognosis biomarkers","author":"Kobeissy","year":"2020"}],"container-title":["Analytica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003267026008329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003267026008329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:09:08Z","timestamp":1787926148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003267026008329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":80,"alternative-id":["S0003267026008329"],"URL":"https:\/\/doi.org\/10.1016\/j.aca.2026.345882","relation":{},"ISSN":["0003-2670"],"issn-type":[{"value":"0003-2670","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced glycomics approach for characterization of IgG glycan alterations and immune modulation in traumatic brain injury","name":"articletitle","label":"Article Title"},{"value":"Analytica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aca.2026.345882","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"345882"}}